Author

M. Blijlevens

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Okonska· 1 shared E. Felley-Bosco· 1 shared E. Smit· 1 shared I. Van der Meulen-Muileman· 1 shared L. Penengo· 1 shared M. Ronner· 1 shared R. de Menezes· 1 shared R. Stahel· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Okonska

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genome-wide silencing screen in mesothelioma cells reveals that loss of function of BAP1 induces chemoresistance to ribonucleotide reductase inhibition: implication for therapy

A. Okonska, S. Buehler, V. Rao, M. Ronner, M. Blijlevens, I. Van der Meulen-Muileman, R. de Menezes, E. Smit, W. Weder, R. Stahel, L. Penengo, V. van Beusechem, E. Felley-Bosco

The paper identifies BAP1's role in regulating RRM2 during replication stress, showing that BAP1 loss increases chemoresistance to ribonucleotide reductase inhibitors in mesothelioma cells.

bioRxiv · Jul 31, 2018Cancer Biology